USP22 was initially regarded as part of an 11 gene “death from cancer signature”, which referred to tumors with a cancer stem cell phenotype.343,344 USP22 is a positive regulator of the NAD-dependent histone deacetylase Sirt1. The gene discussed is USP22; the disease is cancer.